Who Paid My Doc
Fluzone Quadrivalent
Biological Vaccines
NDC 49281-420-10
General payments
$112,353
Research payments
$12,880,078
Through program year 2020, $112,353 in general payments and $12,880,078 in research payments were reported against Fluzone Quadrivalent (Vaccines).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
3 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | General | $112,337 | 4,030 |
| 2020 | Research | $12,880,078 | 1,210 |
| 2019 | General | $16 | 1 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.
The top 5 of 70 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.
The top 5 of 45 states; each share is of general payments naming this product in 2020 where a state was reported.
Records
4,031 general · 1,210 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.